Rodney W. Lappe serves as Executive at Design Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Rodney W. Lappe has executed 3 insider transactions totaling $268.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 29, 2023 involved purchasing 21,000 shares valued at $49.4K.
Rodney W. Lappe currently holds 133,024 shares of Design Therapeutics, Inc. (DSGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rodney W. Lappe has been a net buyer of DSGN stock. They have purchased $268.8K and sold $0 worth of shares.
Rodney W. Lappe's most recent insider trade was on Sep 29, 2023, when they purchased 21,000 shares at $2.35 per share.
Get notified when new Form 4 filings are submitted
| $7.96 |
| Discretionary |
| Mar 30, 2021 | DSGN | $100.0K | Purchase | 5,000 | $20.00 | Discretionary |